Published online before print May 2, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



Divisions of
* Clinical Neurology and
Molecular and Clinical Immunology and
School of Pharmacy, University of Nottingham, United Kingdom
1 Correspondence: Division of Clinical Neurology, Queens Medical Centre, Medical School, University of Nottingham, UK, NG7 2UH. E-mail: cris.constantinescu{at}nottingham.ac.uk
Glucocorticoids affect the immune system by a number of mechanisms, including modulation of cytokine production in lymphocytes. Glucocorticoids suppress T helper cell type 1 immune responses by decreasing the ability of T cells to respond to interleukin (IL)-12, a major inducer of interferon (IFN)-
. IFN-ß increases the expression of the anti-inflammatory cytokine IL-10 and suppresses IL-12. Signaling pathways through IFN-ß and the IL-12 receptor (IL-12R) involve activation by phosphorylation of signal transducer and activator of transcription 4 (STAT4). Our aim was to investigate the effects of dexamethasone on STAT4 activation by IFN-ß and IL-12 in human T cell blasts. We report that dexamethasone decreases IL-12-induced STAT4 phosphorylation and IFN-
production and enhances IFN-ß-induced STAT4 activation and IL-10 production. These effects are associated with a down-regulation of IL-12Rß1 expression but an up-regulation of IFN-ßR. These results indicate that the effect of glucocorticoids on the STAT4 signaling pathway depends on the stimulus activating that pathway.
Key Words: modulation signal transduction
This article has been cited by other articles:
![]() |
A. J. Fahey, R. A. Robins, and C. S. Constantinescu Reciprocal effects of IFN-{beta} and IL-12 on STAT4 activation and cytokine induction in T cells J. Leukoc. Biol., June 1, 2007; 81(6): 1562 - 1567. [Abstract] [Full Text] [PDF] |
||||